Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001628280-18-000664
Filing Date
2018-01-29
Accepted
2018-01-29 16:02:36
Documents
6
Effectiveness Date
2018-01-29

Document Format Files

Seq Description Document Type Size
1 S-8 menlos-8.htm S-8 107515
2 EXHIBIT 5.1 exhibit51.htm EX-5.1 10163
3 EXHIBIT 23.1 exhibit231.htm EX-23.1 2333
4 morrisonfoerstera02.jpg GRAPHIC 10523
5 morrisonfoerstera03.jpg GRAPHIC 10523
6 sanfranciscomnlo51opi_image2.gif GRAPHIC 322
  Complete submission text file 0001628280-18-000664.txt   140145
Mailing Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025
Business Address 4085 CAMPBELL AVENUE, SUITE 200 MENLO PARK CA 94025 650-486-1416
Menlo Therapeutics, Inc. (Filer) CIK: 0001566044 (see all company filings)

EIN.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-222758 | Film No.: 18555534
SIC: 2834 Pharmaceutical Preparations